Drug Research
Quantum Computing Advances Make Way for Lifesaving Therapies
The fact is that there is something very profoundly poetic about the convergence of quantum physics along with pharmaceutical endeavors. In the sophisticated melody of electrons and molecules, a revolution that is quietly unfolding is the quantum computing advance...
Drug Research
Agilent and Tata Institute of Fundamental Research, Hyderabad collaborate to advance scientific frontiers in health and metabolism research
In a significant step toward strengthening India’s efforts in nutrition and metabolism research, Agilent Technologies and the Tata Institute of Fundamental Research (TIFR), Hyderabad have announced a strategic collaboration to support ARUMDA (Advanced Research Unit on Metabolism, Development, and...
Drug Research
Resistance-Evasive Antibiotic for Genes-Free Clinics
In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the treatments.
The researchers have now gone on to develop a platform which can go ahead...
Clinical Trials
Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma
In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission.
It is well to be noted that Sarclisa has received...
Drug Research
Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs
In a recent move, Hengrui Pharma and GSK have inked an agreement when it comes to the development of almost 12 innovative medicines throughout several therapeutic areas, which include immunology, inflammation, oncology, and respiratory.
This partnership is all set to...
Drug Research
Magnetic Particles Steer the Vesicles for Drug Delivery
Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes to precision medicine for the treatment of diseases like cancer. A multi-university team, which...
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















